Skip to search formSkip to main contentSkip to account menu

GSK2245035

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Toll‐like receptor 7 (TLR7) stimulation in the airways may reduce responses to aeroallergens by induction of type 1 interferons… 
2015
2015
Introduction: GSK2245035, a selective toll-like receptor 7 (TLR7) agonist, may reduce allergic reactivity by inducing type 1… 
2014
2014
Introduction GSK2245035 is a novel small molecule TLR7 agonist in development as an immunomodulatory, intranasal treatment for… 
2014
2014
Introduction GSK2245035 is a novel selective TLR7 agonist small molecule capable of inducing strong type 1 IFN-mediated immune…